WNT5A

Protein Wnt-5a is a protein that in humans is encoded by the WNT5A gene.[5][6]

WNT5A
Identifiers
Aliases	WNT5A, hWnt family member 5A
External IDs	OMIM: 164975 MGI: 98958 HomoloGene: 20720 GeneCards: WNT5A
Gene location (Human) Chr. Chromosome 3 (human)[1] Band 3p14.3 Start 55,465,715 bp[1] End 55,490,539 bp[1]
Gene location (Mouse) Chr. Chromosome 14 (mouse)[2] Band 14 A3|14 16.8 cM Start 28,504,750 bp[2] End 28,527,448 bp[2]
Gene ontology Molecular function • protein domain specific binding • GO:0001131, GO:0001151, GO:0001130, GO:0001204 DNA-binding transcription factor activity • chemoattractant activity involved in axon guidance • receptor tyrosine kinase-like orphan receptor binding • receptor binding • cytokine activity • GO:0005110 frizzled binding • receptor ligand activity • GO:0001948 protein binding • phospholipid binding Cellular component • endocytic vesicle membrane • endoplasmic reticulum lumen • extracellular region • cell surface • extracellular exosome • cell membrane • Golgi lumen • clathrin-coated endocytic vesicle membrane • extracellular • clathrin-coated vesicle membrane • extracellular matrix • collagen-containing extracellular matrix • postsynapse • glutamatergic synapse Biological process • somitogenesis • cellular response to retinoic acid • planar cell polarity pathway involved in outflow tract morphogenesis • excitatory synapse assembly • non-canonical Wnt signaling pathway • positive regulation of protein phosphorylation • negative chemotaxis • positive regulation of protein catabolic process • paraxial mesoderm formation • convergent extension involved in axis elongation • positive regulation of protein kinase C activity • cellular response to molecule of bacterial origin • positive regulation of protein localization to synapse • hindgut morphogenesis • positive regulation of JNK cascade • mesodermal to mesenchymal transition involved in gastrulation • regulation of protein localization • heart looping • protein phosphorylation • epithelial cell proliferation involved in mammary gland duct elongation • face development • establishment of epithelial cell apical/basal polarity • notochord morphogenesis • positive regulation of mesenchymal cell proliferation • mesenchymal-epithelial cell signaling • negative regulation of epithelial cell proliferation • planar cell polarity pathway involved in cardiac muscle tissue morphogenesis • cellular response to interferon-gamma • positive regulation of thymocyte apoptotic process • tube closure • positive regulation of non-canonical Wnt signaling pathway • type B pancreatic cell development • negative regulation of mesenchymal cell proliferation • primitive streak formation • cellular response to transforming growth factor beta stimulus • cellular response to calcium ion • dopaminergic neuron differentiation • positive regulation of type I interferon-mediated signaling pathway • cell fate commitment • negative regulation of fat cell differentiation • limb morphogenesis • activation of JUN kinase activity • convergent extension • lung development • positive regulation of fibroblast proliferation • optic cup formation involved in camera-type eye development • hematopoietic stem cell proliferation • embryonic digit morphogenesis • regulation of branching involved in mammary gland duct morphogenesis • regulation of cellular protein localization • negative regulation of axon extension involved in axon guidance • positive regulation of peptidyl-serine phosphorylation • chemorepulsion of dopaminergic neuron axon • positive regulation of transcription, DNA-templated • negative regulation of prostatic bud formation • planar cell polarity pathway involved in cardiac right atrium morphogenesis • positive regulation of endocytosis • morphogenesis of an epithelium • JNK cascade • cartilage development • GO:0032320, GO:0032321, GO:0032855, GO:0043089, GO:0032854 positive regulation of GTPase activity • axis elongation • embryonic limb morphogenesis • positive regulation of cartilage development • neural tube development • pericardium morphogenesis • positive regulation of interleukin-6 production • post-anal tail morphogenesis • convergent extension involved in organogenesis • digestive tract morphogenesis • palate development • cell differentiation • neuron projection morphogenesis • male gonad development • positive regulation of inflammatory response • lateral sprouting involved in mammary gland duct morphogenesis • positive regulation of macrophage cytokine production • positive regulation of epithelial cell proliferation • urinary bladder development • planar cell polarity pathway involved in ventricular septum morphogenesis • positive regulation of JUN kinase activity • establishment of planar polarity • hypophysis morphogenesis • negative regulation of synapse assembly • wound healing • positive regulation of macrophage activation • negative regulation of apoptotic process • positive regulation of ossification • planar cell polarity pathway involved in axis elongation • negative regulation of melanin biosynthetic process • positive regulation of angiogenesis • embryonic skeletal system development • cervix development • uterus development • Wnt signaling pathway, planar cell polarity pathway • Wnt signaling pathway, calcium modulating pathway • activation of MAPK activity • positive regulation of NF-kappaB transcription factor activity • epithelial–mesenchymal transition • canonical Wnt signaling pathway • planar cell polarity pathway involved in pericardium morphogenesis • positive regulation of protein binding • negative regulation of transcription, DNA-templated • ameboidal-type cell migration • midbrain development • planar cell polarity pathway involved in gastrula mediolateral intercalation • positive regulation of protein kinase activity • positive regulation of cell-cell adhesion mediated by cadherin • neurogenesis • activation of protein kinase B activity • positive regulation of endothelial cell proliferation • axonogenesis • non-canonical Wnt signaling pathway via JNK cascade • GO:0032861, GO:0032862, GO:0032856 activation of GTPase activity • positive regulation of cytokine production • vagina development • positive regulation of protein kinase C signaling • development of primary male sexual characteristics • mammary gland branching involved in thelarche • positive regulation of interferon-gamma production • somite development • keratinocyte differentiation • planar cell polarity pathway involved in neural tube closure • axon guidance • negative regulation of BMP signaling pathway • positive regulation of endothelial cell migration • genitalia development • negative regulation of fibroblast growth factor receptor signaling pathway • positive regulation of response to cytokine stimulus • multicellular organism development • cellular protein localization • inhibitory synapse assembly • neural tube closure • determination of left/right symmetry • lens development in camera-type eye • positive regulation of peptidyl-threonine phosphorylation • cochlea morphogenesis • inner ear morphogenesis • positive regulation of T cell chemotaxis • olfactory bulb interneuron development • positive regulation of cell proliferation • positive regulation of neuron projection development • positive regulation of meiotic nuclear division • melanocyte proliferation • cellular response to lipopolysaccharide • cell migration • anterior/posterior axis specification, embryo • chemoattraction of serotonergic neuron axon • positive regulation of transcription from RNA polymerase II promoter • anterior/posterior pattern specification • midgut development • planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation • midbrain dopaminergic neuron differentiation • neuron differentiation • Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation • negative regulation of cell proliferation in midbrain • negative regulation of canonical Wnt signaling pathway • planar cell polarity pathway involved in axon guidance • Wnt signaling pathway • response to organic substance • positive regulation of timing of anagen • membrane organization • positive regulation of canonical Wnt signaling pathway • presynapse assembly • postsynapse assembly • regulation of receptor activity • positive regulation of gene expression • regulation of I-kappaB kinase/NF-kappaB signaling • positive regulation of G-protein coupled receptor protein signaling pathway • regulation of inflammatory response • regulation of synapse organization • secondary palate development • regulation of postsynapse organization • regulation of postsynaptic cytosolic calcium ion concentration • positive regulation of neuron projection arborization • positive regulation of neuron death Sources:Amigo / QuickGO
Orthologs
Species	Human	Mouse
Entrez	7474	22418
Ensembl	ENSG00000114251	ENSMUSG00000021994
UniProt	P41221	P22725
RefSeq (mRNA)	NM_001256105 NM_003392 NM_001377271 NM_001377272	NM_001256224 NM_009524
RefSeq (protein)	NP_001243034 NP_003383 NP_001364200 NP_001364201	NP_001243153 NP_033550
Location (UCSC)	Chr 3: 55.47 – 55.49 Mb	Chr 14: 28.5 – 28.53 Mb
PubMed search	[3]	[4]
Wikidata
View/Edit Human View/Edit Mouse

Function

The WNT gene family consists of structurally related genes that encode secreted signaling lipid modified glycoproteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis.[7] This gene is a member of the WNT gene family. The WNT5A is highly expressed in the dermal papilla of depilated skin. It encodes a protein showing 98%, 98%, and 87% amino acid identity to the mouse, rat and the xenopus Wnt5a protein, respectively. Wnts, specifically Wnt5a, have also been positively correlated and implicated in inflammatory diseases such as rheumatoid arthritis, tuberculosis, and atherosclerosis. A central player and active secretor of Wnt5a in both cancer and these inflammatory diseases are macrophages.[8][9] Experiments performed in Xenopus laevis embryos have identified that human frizzled-5 (hFz5) is the receptor for the Wnt5a ligand and the Wnt5a/hFz5 signaling mediates axis induction.[6] However, non-canonical Wnt5a has also been shown to bind to Ror1/2, RYK, and RTK depending on cell and receptor context to mediate a variety of functions ranging from cell proliferation, polarity, differentiation and apoptosis.[10][11]

Development

The Wnt5a gene is also a key component in posterior development of the female reproductive tract, development of the uterine glands postnatally, and the process of estrogen mediated cellular and molecular responses.[12] Wnt5a is expressed throughout the endometrial stroma of the mammalian female reproductive tracts and is required in the development of the posterior formation of the Müllerian ducts (cervix, vagina).[13] A Wnt5a absence study was performed by Mericskay et al. on mice and showed the anterior Müllerian-derived structures (oviducts and uterine horns) could easily be identified, and the posterior derived structures (cervix and vagina) were absent showing that this gene is a requirement for its development.[12] Other members of the WNT family that are required for the development of the reproductive tract are Wnt4 and Wnt7a.[13] Failure to develop reproductive tract will result in infertility. Not only is the WNT5A gene responsible for this formation but also is significate in the postnatal production of the uterine glands otherwise known as adenogenesis which is essential for adult function.[12] In addition to these two developments Wnt5a it needed for the complete process of estrogen mediated cellular and molecular responses.[12]

Wnt ligands

Wnt ligands are classically described as acting in an autocrine/paracrine manner.[14][15][16] Wnts are also hydrophobic with significant post-translational palmitoylation and glycosylation.[17][18] These post-translational modifications are important for docking to extracellular lipoprotein particles allowing them to travel systemically.[19][20] Additionally, due to the high degree of sequence homology between Wnts many are characterized by their downstream actions.

Clinical significance

Cancer

Wnt5a is implicated in many different types of cancers.[21] However, no consistent correlation occurs between cancer aggressiveness and Wnt5a signaling up-regulation or down-regulation. The WNT5A gene has been shown to encode two distinct isoforms, each with unique functions in the context of cancer.[22] The two isoforms are termed Wnt5a-long (Wnt5a-L) and Wnt5a-short (Wnt5a-S) because Wnt5a-L is 18 amino acids longer than Wnt5a-S.[22] These 18 amino acids appear to have contrasting roles in cancer. Specifically, Wnt5a-L inhibits proliferation and Wnt5a-S increases proliferation.[22] This may account for the discrepancies as to the role of Wnt5a in various cancers; however, the significance of these two isoforms is not completely clear.[23] Elevated levels of beta-catenin in both primary and metastases of malignant melanoma have been correlated to improved survival and a decrease in cell markers of proliferation.[24]

Cardiovascular Disease

Increasing evidence has implicated Wnt5a in chronic inflammatory disorders.[25] In particular Wnt5a has been implicated in atherosclerosis.[26] [27]It has been previously reported that there is an association between Wnt5a mRNA and protein expression and histopathological severity of human atherosclerotic lesions as well as co-expression of Wnt5a and TLR4 in foam cells/macrophages of murine and human atherosclerotic lesions.[28][29] However, the role of Wnt proteins in the process and development of inflammation in atherosclerosis and other inflammatory conditions is not yet clear.

Therapeutics

Some of the benefits of targeting this signaling pathway include:[30]

• Many of the current DNA-targeting anticancer drugs carry the risk of giving rise to secondary tumors or additional primary cancers.

• Preferentially killing rapidly replicating malignant cells via cytotoxic agents cause serious side effects by injuring normal cells, particularly hematopoietic cells, intestinal cells, hair follicle and germ cells.

• Differentiated tumor cells in a state of quiescence are typically not affected by drugs can may account for tumor recurrence.

References

1. GRCh38: Ensembl release 89: ENSG00000114251 - Ensembl, May 2017
2. GRCm38: Ensembl release 89: ENSMUSG00000021994 - Ensembl, May 2017
3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
5. Clark CC, Cohen I, Eichstetter I, Cannizzaro LA, McPherson JD, Wasmuth JJ, Iozzo RV (November 1993). "Molecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14-p21". Genomics. 18 (2): 249–60. doi:10.1006/geno.1993.1463. PMID 8288227.
6. "Entrez Gene: WNT5A wingless-type MMTV integration site family, member 5A".
7. Bhatt PM, Malgor R (November 2014). "Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders". Atherosclerosis. 237 (1): 155–62. doi:10.1016/j.atherosclerosis.2014.08.027. PMC 4252768. PMID 25240110.
8. Blumenthal, Antje; Ehlers, Stefan; Lauber, Jörg; Buer, Jan; Lange, Christoph; Goldmann, Torsten; Heine, Holger; Brandt, Ernst; Reiling, Norbert (2006-08-01). "The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation". Blood. 108 (3): 965–973. doi:10.1182/blood-2005-12-5046. ISSN 0006-4971. PMID 16601243. S2CID 13491469.
9. Sen, Malini; Chamorro, Mario; Reifert, Jack; Corr, Maripat; Carson, Dennis A. (2001-04-01). "Blockade of Wnt-5A/Frizzled 5 signaling inhibits rheumatoid synoviocyte activation". Arthritis & Rheumatism. 44 (4): 772–781. doi:10.1002/1529-0131(200104)44:4<772::aid-anr133>3.0.co;2-l. ISSN 1529-0131. PMID 11315916.
10. Gordon, Michael D.; Nusse, Roel (2006-08-11). "Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors". Journal of Biological Chemistry. 281 (32): 22429–22433. doi:10.1074/jbc.R600015200. ISSN 0021-9258. PMID 16793760.
11. Mikels, Amanda; Minami, Yasuhiro; Nusse, Roel (2009-10-30). "Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling". Journal of Biological Chemistry. 284 (44): 30167–30176. doi:10.1074/jbc.M109.041715. ISSN 0021-9258. PMC 2781572. PMID 19720827.
12. Mericskay M, Kitajewski J, Sassoon D (May 2004). "Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus". Development. 131 (9): 2061–72. doi:10.1242/dev.01090. PMID 15073149.
13. Hayashi K, Yoshioka S, Reardon SN, Rucker EB, Spencer TE, DeMayo FJ, Lydon JP, MacLean JA (February 2011). "WNTs in the neonatal mouse uterus: potential regulation of endometrial gland development". Biology of Reproduction. 84 (2): 308–19. doi:10.1095/biolreprod.110.088161. PMC 3071266. PMID 20962251.
14. Corbett L, Mann J, Mann DA (2015-01-01). "Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer Cells". PLOS ONE. 10 (11): e0142794. Bibcode:2015PLoSO..1042794C. doi:10.1371/journal.pone.0142794. PMC 4643911. PMID 26566235.
15. Clevers H, Nusse R (June 2012). "Wnt/β-catenin signaling and disease". Cell. 149 (6): 1192–205. doi:10.1016/j.cell.2012.05.012. PMID 22682243.
16. Anagnostou SH, Shepherd PR (December 2008). "Glucose induces an autocrine activation of the Wnt/beta-catenin pathway in macrophage cell lines". The Biochemical Journal. 416 (2): 211–8. doi:10.1042/BJ20081426. PMID 18823284. S2CID 1178267.
17. Logan CY, Nusse R (2004-10-08). "The Wnt signaling pathway in development and disease". Annual Review of Cell and Developmental Biology. 20 (1): 781–810. CiteSeerX 10.1.1.322.311. doi:10.1146/annurev.cellbio.20.010403.113126. PMID 15473860.
18. Kurayoshi M, Yamamoto H, Izumi S, Kikuchi A (March 2007). "Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling". The Biochemical Journal. 402 (3): 515–23. doi:10.1042/BJ20061476. PMC 1863570. PMID 17117926.
19. Panáková D, Sprong H, Marois E, Thiele C, Eaton S (May 2005). "Lipoprotein particles are required for Hedgehog and Wingless signalling". Nature. 435 (7038): 58–65. Bibcode:2005Natur.435...58P. doi:10.1038/nature03504. PMID 15875013. S2CID 4347286.
20. Neumann S, Coudreuse DY, van der Westhuyzen DR, Eckhardt ER, Korswagen HC, Schmitz G, Sprong H (March 2009). "Mammalian Wnt3a is released on lipoprotein particles". Traffic. 10 (3): 334–43. doi:10.1111/j.1600-0854.2008.00872.x. hdl:1874/33221. PMID 19207483. S2CID 29594183.
21. Asem MS, Buechler S, Wates RB, Miller DL, Stack MS (August 2016). "Wnt5a Signaling in Cancer". Cancers. 8 (9): 79. doi:10.3390/cancers8090079. PMC 5040981. PMID 27571105.
22. Bauer M, Bénard J, Gaasterland T, Willert K, Cappellen D (2013). "WNT5A encodes two isoforms with distinct functions in cancers". PLOS ONE. 8 (11): e80526. Bibcode:2013PLoSO...880526B. doi:10.1371/journal.pone.0080526. PMC 3832467. PMID 24260410.
23. Kumawat K, Gosens R (February 2016). "WNT-5A: signaling and functions in health and disease". Cellular and Molecular Life Sciences. 73 (3): 567–87. doi:10.1007/s00018-015-2076-y. PMC 4713724. PMID 26514730.
24. Chien, Andy J.; Moore, Erin C.; Lonsdorf, Anke S.; Kulikauskas, Rima M.; Rothberg, Bonnie Gould; Berger, Aaron J.; Major, Michael B.; Hwang, Sam T.; Rimm, David L. (2009-01-27). "Activated Wnt/ß-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model". Proceedings of the National Academy of Sciences. 106 (4): 1193–1198. Bibcode:2009PNAS..106.1193C. doi:10.1073/pnas.0811902106. ISSN 0027-8424. PMC 2626610. PMID 19144919.
25. Katoh M, Katoh M (2007). "STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review)". Int. J. Mol. Med. 19 (2): 273–8. PMID 17203201.
26. Bhatt, Pooja M.; Malgor, Ramiro (2014). "Wnt5a: A player in the pathogenesis of atherosclerosis and other inflammatory disorders". Atherosclerosis. 237 (1): 155–162. doi:10.1016/j.atherosclerosis.2014.08.027. PMC 4252768. PMID 25240110.
27. Akoumianakis, Ioannis; Sanna, Fabio; Margaritis, Marios; Badi, Ileana; Akawi, Nadia; Herdman, Laura; Coutinho, Patricia; Fagan, Harry; Antonopoulos, Alexios S. (2019-09-18). "Adipose tissue–derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of NADPH oxidases". Science Translational Medicine. 11 (510): eaav5055. doi:10.1126/scitranslmed.aav5055. hdl:1983/a397d5fa-6ef7-474a-a60f-4f8bb2bd4986. ISSN 1946-6234. PMC 7212031. PMID 31534019.
28. Bhatt, Pooja M.; Lewis, Christopher J.; House, Denise L.; Keller, Chad M.; Kohn, Leonard D.; Silver, Mitchell J.; McCall, Kelly D.; Goetz, Douglas J.; Malgor, Ramiro (2012-01-01). "Increased Wnt5a mRNA Expression in Advanced Atherosclerotic Lesions, and Oxidized LDL Treated Human Monocyte-Derived Macrophages". The Open Circulation & Vascular Journal. 5: 1–7. doi:10.2174/1877382601205010001. ISSN 1877-3826. PMC 4270053. PMID 25530821.
29. Christman, Mark A.; Goetz, Douglas J.; Dickerson, Eric; McCall, Kelly D.; Lewis, Christopher J.; Benencia, Fabian; Silver, Mitchell J.; Kohn, Leonard D.; Malgor, Ramiro (2008-06-01). "Wnt5a is expressed in murine and human atherosclerotic lesions". American Journal of Physiology. Heart and Circulatory Physiology. 294 (6): H2864–H2870. doi:10.1152/ajpheart.00982.2007. ISSN 0363-6135. PMID 18456733.
30. Dihlmann, Susanne; von Knebel Doeberitz, Magnus (2005-02-10). "Wnt/β-catenin-pathway as a molecular target for future anti-cancer therapeutics". International Journal of Cancer. 113 (4): 515–524. doi:10.1002/ijc.20609. ISSN 1097-0215. PMID 15472907. S2CID 72668377.

Further reading

• Mericskay M, Kitajewski J, Sassoon D (May 2004). "Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus". Development. 131 (9): 2061–72. doi:10.1242/dev.01090. PMID 15073149.
• Hayashi K, Yoshioka S, Reardon SN, Rucker EB, Spencer TE, DeMayo FJ, Lydon JP, MacLean JA (February 2011). "WNTs in the neonatal mouse uterus: potential regulation of endometrial gland development". Biology of Reproduction. 84 (2): 308–19. doi:10.1095/biolreprod.110.088161. PMC 3071266. PMID 20962251.
• "Wnt5a". Signaling Gateway Molecule Pages.
• Smolich BD, McMahon JA, McMahon AP, Papkoff J (December 1993). "Wnt family proteins are secreted and associated with the cell surface". Molecular Biology of the Cell. 4 (12): 1267–75. doi:10.1091/mbc.4.12.1267. PMC 275763. PMID 8167409.
• Danielson KG, Pillarisetti J, Cohen IR, Sholehvar B, Huebner K, Ng LJ, Nicholls JM, Cheah KS, Iozzo RV (December 1995). "Characterization of the complete genomic structure of the human WNT-5A gene, functional analysis of its promoter, chromosomal mapping, and expression in early human embryogenesis". The Journal of Biological Chemistry. 270 (52): 31225–34. doi:10.1074/jbc.270.52.31225. PMID 8537388.
• Bonaldo MF, Lennon G, Soares MB (September 1996). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome Research. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID 8889548.
• He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H (March 1997). "A member of the Frizzled protein family mediating axis induction by Wnt-5A". Science (Submitted manuscript). 275 (5306): 1652–4. doi:10.1126/science.275.5306.1652. PMID 9054360. S2CID 36777692.
• Wright M, Aikawa M, Szeto W, Papkoff J (September 1999). "Identification of a Wnt-responsive signal transduction pathway in primary endothelial cells". Biochemical and Biophysical Research Communications. 263 (2): 384–8. doi:10.1006/bbrc.1999.1344. PMID 10491302.
• Gazit A, Yaniv A, Bafico A, Pramila T, Igarashi M, Kitajewski J, Aaronson SA (October 1999). "Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response". Oncogene. 18 (44): 5959–66. doi:10.1038/sj.onc.1202985. PMID 10557084.
• Saitoh T, Mine T, Katoh M (May 2002). "Frequent up-regulation of WNT5A mRNA in primary gastric cancer". International Journal of Molecular Medicine. 9 (5): 515–9. doi:10.3892/ijmm.9.5.515. PMID 11956659.
• Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM (April 2002). "Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma". Cancer Cell. 1 (3): 279–88. doi:10.1016/S1535-6108(02)00045-4. PMID 12086864.
• Saitoh T, Katoh M (September 2002). "Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFalpha in MKN45 cells and up-regulation of WNT5B by beta-estradiol in MCF-7 cells". International Journal of Molecular Medicine. 10 (3): 345–9. doi:10.3892/ijmm.10.3.345. PMID 12165812.
• Murphy LL, Hughes CC (October 2002). "Endothelial cells stimulate T cell NFAT nuclear translocation in the presence of cyclosporin A: involvement of the wnt/glycogen synthase kinase-3 beta pathway". Journal of Immunology. 169 (7): 3717–25. doi:10.4049/jimmunol.169.7.3717. PMID 12244165.
• Thrasivoulou C, Millar M, Ahmed A (December 2013). "Activation of intracellular calcium by multiple Wnt ligands and translocation of β-catenin into the nucleus: a convergent model of Wnt/Ca2+ and Wnt/β-catenin pathways". The Journal of Biological Chemistry. 288 (50): 35651–9. doi:10.1074/jbc.M112.437913. PMC 3861617. PMID 24158438.
• Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K (January 2003). "The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling". Molecular and Cellular Biology. 23 (1): 131–9. doi:10.1128/MCB.23.1.131-139.2003. PMC 140665. PMID 12482967.
• Hocevar BA, Mou F, Rennolds JL, Morris SM, Cooper JA, Howe PH (June 2003). "Regulation of the Wnt signaling pathway by disabled-2 (Dab2)". The EMBO Journal. 22 (12): 3084–94. doi:10.1093/emboj/cdg286. PMC 162138. PMID 12805222.
• Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S, Nagayama M (July 2003). "Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells". Cancer Science. 94 (7): 593–7. doi:10.1111/j.1349-7006.2003.tb01488.x. PMID 12841867. S2CID 46098300.
• Glinsky GV, Glinskii AB, Stephenson AJ, Hoffman RM, Gerald WL (March 2004). "Gene expression profiling predicts clinical outcome of prostate cancer". The Journal of Clinical Investigation. 113 (6): 913–23. doi:10.1172/JCI20032. PMC 362118. PMID 15067324.
• Nishioka K, Dennis JE, Gao J, Goldberg VM, Caplan AI (April 2005). "Sustained Wnt protein expression in chondral constructs from mesenchymal stem cells". Journal of Cellular Physiology. 203 (1): 6–14. doi:10.1002/jcp.20196. PMID 15389636. S2CID 35609184.
• Blanc E, Roux GL, Bénard J, Raguénez G (February 2005). "Low expression of Wnt-5a gene is associated with high-risk neuroblastoma". Oncogene. 24 (7): 1277–83. doi:10.1038/sj.onc.1208255. PMID 15592517.
• Kremenevskaja N, von Wasielewski R, Rao AS, Schöfl C, Andersson T, Brabant G (March 2005). "Wnt-5a has tumor suppressor activity in thyroid carcinoma". Oncogene. 24 (13): 2144–54. doi:10.1038/sj.onc.1208370. PMID 15735754.
• Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P, Thrasivoulou C, Masters JR, Ahmed A (May 2010). Hotchin NA (ed.). "A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer". PLOS ONE. 5 (5): e10456. Bibcode:2010PLoSO...510456W. doi:10.1371/journal.pone.0010456. PMC 2864254. PMID 20454608.